ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 30
Summary
- Conditions
- HIV
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01535235
- Collaborators
- amfAR, The Foundation for AIDS Research
- Investigators
- Principal Investigator: Hiroyu Hatano, MD University of California, San Francisco